Project Grant P01AI179570
Award Date
7/23/25
Completion Date
5/31/30
Dollars Obligated
$2.7M
Federal Agency
National Institute of Allergy and Infectious Diseases
Awardee
Yale Univ (FL6GV84CKN57)
Federal Grant Program
93.855
Assistance Type
Project Grant
Place of Performance
Connecticut, USA
Similar Awards
This $797,735 Project Grant, awarded by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), aims to elucidate the cellular and molecular mechanisms governing heightened immune responses in neonates. The research project will utilize a novel mouse model to investigate how the innate immune system detects and mediates sterile inflammation during early life development, with the goal of developing targeted...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) provides $693,465 to Cornell University over a period from January 2025 to December 2029. The funding supports a research project titled "Mapping Infant and Adult T Cell Immunity" that aims to construct a molecular atlas of T cell development in lymph nodes and determine how cellular interactions and communication networks change during CD8+ T...
This Project Grant award, valued at $735,078, was provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research federal grant program (CFDA 93.855). The funding supports a 5-year research project to investigate the molecular mechanisms of innate immune memory in humans, with a focus on understanding the epigenetic determinants that enable long-lasting "trained immunity" in myeloid and lymphoid progenitor cells. The...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $639,084 Project Grant under the Allergy and Infectious Diseases Research (CFDA 93.855) federal grant program to Childrens Hospital Medical Center in Cincinnati, Ohio. The grant, awarded on March 19, 2025, supports a research project titled "NAIVE CD8 T CELL FUNCTIONAL HETEROGENEITY" that aims to elucidate the heterogeneity of naive CD8 T cells and understand how this impacts immune responses and T cell...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $2,685,326 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to Yale University. The grant supports research to examine the role of CD101 in immune suppression, characterize functional responses of CD101-high neutrophils, investigate the mechanisms for Wnt5 to regulate splenic extramedullar hematopoiesis, and determine the transcription factors that control the molecular and...
This federal Project Grant award for $246,623.00 was provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855). The grant supports research at New York University School of Medicine to study the molecular control of tolerogenic dendritic cell function. The research aims to characterize the dendritic cell subset responsible for maintaining T cell tolerance, including investigating aberrant cytokine...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $242,310 to Yale University to conduct research aimed at elucidating the cellular and molecular mechanisms governing the catabolism (breakdown) of immunoglobulin E (IgE). The research project seeks to uncover the receptors and cell types responsible for IgE clearance, as well as the impact of IgE glycosylation on its...
This federal Project Grant award of $425,226.00, provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), aims to establish the feasibility of engineering "trained innate immunity" using biomaterial implants. The research project, conducted by the Regents of the University of Michigan, will investigate how scaffold properties like pore size and degradation time can modulate the innate...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $192,260 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to the University of Virginia (UVA). The 5-year grant, active from March 1, 2025 to February 28, 2030, supports research to characterize the systemic and mucosal immune response to adenovirus 40/41 infection in Bangladeshi children. The grant has two key objectives: 1) Describe the antibody repertoire to adenovirus 40/41 in...
This Project Grant award, valued at $242,310.00, was provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research Federal Grant Program (CFDA 93.855). The grant supports research conducted by Weill Medical College of Cornell University to investigate how the early-life intestinal microbiome and maternal antibodies influence the trafficking of commensal microbes to the thymus, which is critical for the development of the...